A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Simple Search

You could also try: resembling (46)

Guidance for new grant holders_FINAL_June2021

Description
Guidance for new UHS* grant holders Congratulations, you’ve been awarded some research funding! Now what? What are the key things
Url
/Media/Southampton-Clinical-Research/Grants/Download/Guidance-for-new-grant-holders-FINAL-June2021.pdf

Ibrutinib

Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia Regimen Ibrutinib • CLL – Ibrutinib Indication • NICE TA 429 recommends ibrutinib alone within its marketing authorisation as
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Ibrutinib.pdf

Chlorambucil_7day

Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia Chlorambucil (7 day) There are several versions of this protocol each using a different dose or
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Chlorambucil-7day.pdf

Chlorambucil_14day

Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia Chlorambucil (14 day) There are several versions of this protocol each using a different dose or
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Chlorambucil-14day.pdf

Topotecan (1,8,15)

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER TOPOTECAN INTRAVENOUS (1, 8, 15) Regimen Ovary – Topotecan (1, 8, 15) Indication Second-line or subsequent treatment
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Topotecan1815.pdf

Topotecan (1,8)

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER TOPOTECAN INTRAVENOUS (1, 8) Regimen Ovary – Topotecan (1, 8) Indication Second-line or subsequent treatment of platinum
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Topotecan18.pdf

Topotecan (1,2,3,4,5)

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER TOPOTECAN INTRAVENOUS (1, 2, 3, 4, 5) Regimen Ovary – Topotecan (1, 2, 3, 4, 5) Indication Second
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Topotecan12345.pdf

Gemcitabine ver1

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER GEMCITABINE Regimen Ovarian – Gemcitabine Indication The treatment of advanced ovarian cancer WHO Performance status 0, 1, 2
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Gemcitabine-ver1.pdf

Etoposide PO

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER ETOPOSIDE ORAL Regimen Ovary-Etoposide Oral Indication Second line or subsequent treatment of recurrent platinum resistant ovarian
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/EtoposidePO.pdf

Cyclophosphamide PO

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CYCLOPHOSPHAMIDE ORAL Regimen Ovary – Cyclophosphamide Oral Indication Relapsed/refractory ovarian cancer in patients unsuitable for other treatments
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CyclophosphamidePO.pdf
311 to 320 of 757
Previous … 30 31 32 33 34 … Next